Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Inventories — Work-in-process: $5,634M in FY2025, down 7.7% from a year earlier.
Latest, FY2025
5,634
Period ended Dec 31, 2025
Change on a year earlier
-7.7%
6,101 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Stage-of-completion breakdown of current inventories plus strategic long-cycle noncurrent inventories and supplier finance obligations.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inventories — Work-in-process ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,634 | -7.7% | Form 10-Q (filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 6,101 | +7.3% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 5,688 | +3.1% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 5,519 | +24.8% | Form 10-K (filed 2024-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 4,424 | -0.3% | Form 10-K (filed 2023-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 4,436 | +7.4% | Form 10-K (filed 2022-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 4,131 | -12.1% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 4,701 | +20.3% | Form 10-K (filed 2020-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 3,908 | +5.7% | Form 10-K (filed 2019-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 3,696 | -6.0% | Form 10-K (filed 2018-02-22) ↗ |
| FY2015 | Dec 31, 2015 | 3,932 | – | Form 10-K (filed 2017-02-23) ↗ |
Breakdown
What makes up inventories — Work-in-process
- Inventories — Finished goods ($M)4,113 · FY2025
- Inventories — Raw materials & supplies ($M)907 · FY2025
- Noncurrent inventories (included in Other noncurrent assets) ($M)2,370 · FY2025
- Supplier Finance Program — Confirmed obligations outstanding ($M)574 · FY2025
- Supplier Finance Program — Obligations added during year ($M)2,115 · FY2025
- Supplier Finance Program — Obligations settled during year ($M)2,229 · FY2025
Cite this data
StockData. (2026). Pfizer Inventories — Work-in-process ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/inv-wip
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.